What is the recommended treatment for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Typhoid Fever

First-Line Treatment Recommendation

Azithromycin is the preferred first-line treatment for typhoid fever, particularly in areas with high fluoroquinolone resistance, at a dose of 500 mg once daily for 7 days in adults or 20 mg/kg/day (maximum 1g/day) for 7 days in children. 1, 2, 3

Treatment Algorithm Based on Resistance Patterns

For Quinolone-Resistant or Unknown Susceptibility Strains

  • Start with azithromycin as empiric therapy, especially for cases originating from South Asia where fluoroquinolone resistance exceeds 70% 1, 2, 4
  • Azithromycin demonstrates superior outcomes with lower risk of clinical failure (OR 0.48) and shorter hospital stays compared to fluoroquinolones 1, 3
  • Risk of relapse is significantly lower with azithromycin (OR 0.09) compared to ceftriaxone 1, 3

For Fully Susceptible Strains

  • Fluoroquinolones (ciprofloxacin or ofloxacin) remain effective when susceptibility is confirmed 1, 3, 5
  • However, avoid empiric ciprofloxacin use for cases from South Asia due to resistance rates approaching 96% in some regions 6, 3, 7

For Severe Cases Requiring Parenteral Therapy

  • Ceftriaxone 1-2g IV/IM daily for adults or 50-80 mg/kg/day (maximum 2g/day) for children for 5-7 days 1, 2, 3
  • Transition to oral azithromycin once clinical improvement occurs and temperature has been normal for 24 hours 1, 2

Specific Dosing Guidelines

Adults

  • Azithromycin: 500 mg once daily for 7-14 days 1, 3
  • Ceftriaxone: 1-2g IV/IM daily for 5-7 days 1
  • Ciprofloxacin (if susceptible): 500 mg twice daily per FDA labeling 5

Children

  • Azithromycin: 20 mg/kg/day (maximum 1g/day) for 7 days 1, 2
  • Ceftriaxone: 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days 1, 2
  • Cefixime: 8 mg/kg/day as single daily dose for 7-14 days 2

Critical Diagnostic Considerations

  • Obtain blood cultures before starting antibiotics whenever possible, as they have the highest yield within the first week of symptom onset 1, 3
  • For patients with sepsis features, start broad-spectrum antimicrobial therapy immediately after collecting blood cultures 2, 3
  • Blood culture sensitivity is limited; bone marrow culture remains the reference standard but is rarely practical 4

Monitoring and Expected Response

  • Expect fever clearance within 4-5 days of appropriate therapy 1, 3
  • Monitor for clinical improvement; if no response by day 5, consider resistance or alternative diagnosis 1
  • Complete the full 7-day course to prevent relapse, which occurs in 10-15% of inadequately treated cases 1

Management of Complications

  • Intestinal perforation occurs in 10-15% of patients with illness duration exceeding 2 weeks 1
  • Surgical intervention with simple excision and closure is required for perforation, reported successful in up to 88.2% of cases 1
  • Do not delay surgical consultation if perforation is suspected 1

Common Pitfalls to Avoid

  • Never use ciprofloxacin empirically for cases from South or Southeast Asia due to widespread resistance 6, 3, 4
  • Do not discontinue antibiotics prematurely; complete the full course even if fever resolves early 1
  • Avoid combination typhoid-paratyphoid vaccines; only monovalent S. typhi preparations should be used 6
  • Do not rely on Widal test alone for diagnosis; it has poor specificity and sensitivity 8

Adverse Effects and Drug Interactions

  • Common azithromycin adverse effects include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 1, 3
  • Monitor for potential drug interactions with azithromycin, particularly QT-prolonging medications 1
  • Ceftriaxone shows 100% sensitivity in most regions with minimal adverse effects 9, 8

Prevention Strategies

  • Typhoid vaccination is recommended for travelers to endemic areas, particularly Latin America, Asia, and Africa 6, 1
  • Vaccination provides incomplete protection (does not protect against paratyphoid) and should not replace food and water safety precautions 6, 1, 3
  • Hand hygiene and appropriate food safety practices remain essential 1

Emerging Resistance Concerns

  • Extensively drug-resistant strains have emerged in Pakistan, resistant to both fluoroquinolones and ceftriaxone 4, 9
  • Multidrug resistance (to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole) remains common, affecting 58% of isolates in some regions 7
  • Always consider local resistance patterns when selecting empiric therapy, as these vary geographically and change over time 2, 9

References

Guideline

Treatment for Patients with Significant Typhoid Titers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Enteric Fever in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Study of clinical profile and antibiotic response in typhoid fever.

Indian journal of medical microbiology, 2005

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.